BICLUSTER_ID : DNREG-276
PATHOGENS /5/ : pseudomonas aeruginosa,streptococcus pneumoniae,helicobacter pylori,aeromonas caviae,mycobacterium tuberculosis
TARGETS /4/ : KIF11, MTHFD1, DLAT, VDAC3
Gene SetLeading Edge Genes
BLUM RESPONSE TO SALIRASIB DNBUB1B, ABCD3, MYCBP, TTK, MSH6, KIF11, MAD2L1, ZWINT, MTHFD1, TMPO, POLE2, VDAC3, CENPA, UBE2E3, GPSM2, LSM5
HORIUCHI WTAP TARGETS DNBUB1B, ABCD3, TTK, KIF11, MAD2L1, DLAT, TMPO, UNG, CCNB1, CENPA
KOBAYASHI EGFR SIGNALING 24HR DNBUB1B, TTK, MSH6, KIF11, MAD2L1, ZWINT, TMPO, UNG, POLE2, CCNB1, CENPA, CSE1L, GPSM2
LINDGREN BLADDER CANCER CLUSTER 3 UP
REACTOME CELL CYCLE MITOTICBUB1B, KIF2A, MAD2L1, ZWINT, POLE2, CCNB1, CENPA, RFC4, RPA3, PRIM1
PUJANA BRCA1 PCC NETWORK
BOYAULT LIVER CANCER SUBCLASS G123 UP
RHODES UNDIFFERENTIATED CANCER
ODONNELL TARGETS OF MYC AND TFRC DN
REACTOME MITOTIC PROMETAPHASEKIF2A, PPP2R1B, STAG1, MAD2L1, ZWINT, CENPA
MOREAUX B LYMPHOCYTE MATURATION BY TACI DN
MARKEY RB1 ACUTE LOF DN
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY UP
HOFFMANN LARGE TO SMALL PRE BII LYMPHOCYTE UP
REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS
NCI MITOTIC PROMETAPHASE
YU MYC TARGETS UP
BOYAULT LIVER CANCER SUBCLASS G23 UP
FERREIRA EWINGS SARCOMA UNSTABLE VS STABLE UP
CHIANG LIVER CANCER SUBCLASS UNANNOTATED DN
NCI MRNA SPLICING MAJOR PATHWAY
KINSEY TARGETS OF EWSR1 FLII FUSION UP
FOURNIER ACINAR DEVELOPMENT LATE 2
MORI LARGE PRE BII LYMPHOCYTE UP
CORUM SPLICEOSOME
MOREAUX MULTIPLE MYELOMA BY TACI DN
VANTVEER BREAST CANCER METASTASIS DN
SHEDDEN LUNG CANCER POOR SURVIVAL A6
SCIBETTA KDM5B TARGETS DN
SCHLOSSER MYC TARGETS AND SERUM RESPONSE DN
MORI EMU MYC LYMPHOMA BY ONSET TIME UP
DODD NASOPHARYNGEAL CARCINOMA DN
BENPORATH PROLIFERATION
Color legend
q-value-1-0.2-0.05-0.01-0.001-0.0001
Color
TABLE OF Q-VALUES
pseudomonas aeruginosamycobacterium tuberculosisaeromonas caviastreptococcus pneumoniae d39helicobacter pylori kx1 npgecGeneSet Name
-0.00107 -0.00002 -0.01909 -0.05952 -0.00297BLUM_RESPONSE_TO_SALIRASIB_DN
-0.00235 -0.00035 -0.02805 -0.01609 -0.00232HORIUCHI_WTAP_TARGETS_DN
-0.08946 -0.00020 -0.00012 -0.07071 -0.00610KOBAYASHI_EGFR_SIGNALING_24HR_DN
-0.01432 -0.00491 -0.00804 -0.04361 -0.00109LINDGREN_BLADDER_CANCER_CLUSTER_3_UP
-0.00096 -0.00028 -0.01738 -0.03832 -0.00054REACTOME_CELL_CYCLE_MITOTIC
-0.01546 -0.12426 -0.02210 -0.10265 -0.03725PUJANA_BRCA1_PCC_NETWORK
-0.01718 -0.00026 -0.02327 -0.06172 -0.10257BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
-0.02924 -0.00660 -0.08510 -0.05583 -0.00202RHODES_UNDIFFERENTIATED_CANCER
-0.09189 -0.03017 -0.10956 -0.12637 -0.02871ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN
-0.00072 -0.00015 -0.01572 -0.02070 -0.00233REACTOME_MITOTIC_PROMETAPHASE
-0.07235 -0.11011 -0.02451 -0.03950 -0.03248MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
-0.08917 -0.00002 -0.03439 -0.06105 -0.00100MARKEY_RB1_ACUTE_LOF_DN
-0.00868 -0.05761 -0.17884 -0.15969 -0.03512RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
-0.11187 -0.00013 -0.08582 -0.18584 -0.00059HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP
-0.06489 -0.00019 -0.17521 -0.06131 -0.17124REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS
-0.00094 -0.00003 -0.05777 -0.02527 -0.00299NCI_MITOTIC_PROMETAPHASE
-0.12022 -0.00255 -0.00075 -0.02289 -0.00084YU_MYC_TARGETS_UP
-0.17995 -0.07599 -0.01335 -0.12725 -0.02927BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
-0.05357 -0.00357 -0.15511 -0.01917 -0.01555FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP
-0.00006 -0.14510 -0.00408 -0.02845 -0.00179CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
-0.12422 -0.02478 -0.00363 -0.15699 -0.01681NCI_MRNA_SPLICING___MAJOR_PATHWAY
-0.00097 -0.00940 -0.00039 -0.02023 -0.00330KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP
-0.11866 -0.09804 -0.00027 -0.14008 -0.00300FOURNIER_ACINAR_DEVELOPMENT_LATE_2
-0.02813 -0.00009 -0.08123 -0.00446 -0.01648MORI_LARGE_PRE_BII_LYMPHOCYTE_UP
-0.13655 -0.10848 -0.12815 -0.07735 -0.15924CORUM_SPLICEOSOME
-0.01021 -0.00807 -0.00005 -0.00101 -0.04602MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
-0.00024 -0.15585 -0.00876 -0.04658 -0.08145VANTVEER_BREAST_CANCER_METASTASIS_DN
-0.01610 -0.00051 -0.00092 -0.07798 -0.03282SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6
-0.02302 -0.19518 -0.10579 -0.01880 -0.00090SCIBETTA_KDM5B_TARGETS_DN
-0.04099 -0.17840 -0.08221 -0.12880 -0.17846SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN
-0.04215 -0.12221 -0.03498 -0.00067 -0.09524MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
-0.00288 -0.17486 -0.06032 -0.01300 -0.06590DODD_NASOPHARYNGEAL_CARCINOMA_DN
-0.00017 -0.03741 -0.01238 -0.00014 -0.00727BENPORATH_PROLIFERATION